SARS-CoV-2 Rapid Antigen Test. Box of 25
The SARS‑CoV‑2 Rapid Antigen Test is a rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS‑CoV‑2 present in the human nasopharynx. This test is intended to detect antigen from the SARS‑CoV‑2 virus in individuals suspected of COVID‑19 and provides results in 30 minutes.
Each test contains:
- Test device (individual in foil pouch with desiccant)
- Extraction buffer tube
- Nozzle cap
- Sterile Swab
- Film (can be attached to the test device when performing outdoor testing)
- Instructions for use and quick reference guide
Each kit contains 25 individually packaged, ready-to-use COVID-19 antigen testing tests.
This pack comes with additional items to support administering the test:
- 25 Biohazard waste yellow bags. (BS EN 61340-5-1:2007)
This product is strictly intended for professional use in laboratory and point of care environments.
Coronaviruses can cause a variety of acute and chronic diseases. Common signs of a person infected with coronavirus include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. The 2019 new coronavirus, or SARS‑CoV‑2, was discovered in 2019 after viral pneumonia cases in Wuhan and a pandemic was declared by the World Health Organisation on March 11, 2020. WHO confirmed that COVID‑19 can cause colds and more serious diseases such as severe acute respiratory syndrome (SARS).
The COVID-19 antigen test is intended for professional use only.
Clinical Performance of the SARS-CoV-2 Rapid test.
The test was found to have a high accuracy, firstly, a sensitivity of 96.52% and secondly a specificity of 99.68%. This was determined from a sample cohort of 426 samples from two independent study centres.
Reading and interpreting results
A coloured line appears in the top section of the results window to show that the test is working properly. This line is the control line (C). Even if the control line is faint or not uniform, the test should be considered to have been performed properly. If no control line is visible the test result should be considered as invalid.
In the case of a positive result, a coloured line appears in the lower section of the result window. This line is the test line of the SARS‑CoV‑2 antigen (T).
Even if the test line is very faint or not uniform the test result should be interpreted as a positive result.
COVID-19 self-swab for healthcare staff Video
Lateral Flow self-swab video tutorial for healthcare staff
Asymptomatic COVID-19 testing is being made available to all patient-facing healthcare staff.
This short training video provides step-by-step instructions on self-administering a Lateral Flow COVID-19 test. It covers the use of test packs, instructions for individual tests and each step of the evaluation process.
The test itself is quick and relatively easy to use, but please watch the video all the way through before commencing the self-swab process. This will help to ensure the tests are carried out correctly, and the results are as accurate and reliable as possible.